Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
Date:11/7/2011

SAN DIEGO, Nov. 7, 2011 /PRNewswire/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS), a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its program highlights and financial results for the third quarter ended September 30, 2011.

Acquisition by Roche in Progress

  • On October 17, 2011, Anadys announced that it had entered into a definitive merger agreement to be acquired by Roche (SIX: RO, ROG; OTCQX: RHHBY). Under the terms of the merger agreement, Roche has commenced an all cash tender offer for all outstanding shares of common stock of Anadys at USD 3.70 per share.  The tender offer is expected to close within the fourth quarter of 2011.

  • "With Roche's considerable capabilities and experience in HCV, we believe the acquisition of Anadys by Roche provides the best chance for our development-stage agents to reach patients," said Steve Worland, Ph.D, President and CEO of Anadys.  "We look forward to an expeditious close and the continuing advancement of our agents within the Roche portfolio."

    Recent Setrobuvir Program Highlights

  • On October 13, 2011, Anadys released positive interim antiviral response and safety data from an ongoing Phase IIb study of setrobuvir in combination with pegylated interferon and ribavirin (P/R) in genotype 1 hepatitis C patients.  Through 12 weeks in the treatment-naïve and prior partial responders/ relapsers groups, setrobuvir plus P/R demonstrated strong antiviral response and the incidence of viral breakthrough rate was low.  Response in the partial responders/ relapsers group was comparable to response in the treatment-naïve group.  Through a median dosing duration of 19 weeks, setrobuvir was generally well tolerated and demonstrated a favorable safety profile with adverse ev
    '/>"/>

  • SOURCE Anadys Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals Inc. in Connection with the Sale of the Company to Roche Holding AG
    2. Anadys Announces Agreement To Be Acquired By Roche
    3. Anadys Setrobuvir Named One of Windhovers Top 10 Most Interesting Infectious Disease Projects to Watch
    4. Anadys Announces Issuance of U.S. Patent Covering Setrobuvir (ANA598)
    5. Anadys Pharmaceuticals Reports First Quarter 2011 Financial Results and Highlights
    6. Anadys Pharmaceuticals Appoints Barry Labinger to Its Board of Directors
    7. Anadys Pharmaceuticals to Present at the Cowen & Company Healthcare Conference
    8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
    9. Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference
    10. Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
    11. Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... 2014  Mark Riccio, director of Cornell University,s ... using the online crowd-funding platform Kickstarter to bring ... researchers and would-be superheros everywhere: "for FREE." Riccio,s ... do if you had Superman,s X-ray vision?" The ... everywhere, from elementary through high school students, academic ...
    (Date:8/22/2014)... , August 22, 2014 ... TVs Today Lincor announced general availability of ... solution that delivers a range of education, entertainment and ...      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , " ... point of care patient engagement to bedside smart devices, ...
    (Date:8/22/2014)... COLORADO SPRINGS, Colo. , Aug. 22, 2014 ... Company specializing in cannabis formulation-based drug development and ... of UFCM iCare,s third international medical cannabis conference ... Strasbourg, France , on October ... experts with other stakeholders, such as researchers, health ...
    Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2Lincor Unveils Next Generation TV-based Patient Engagement Solution 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3
    (Date:8/22/2014)... European Society for Medical Oncology (ESMO), the leading ... the names of three outstanding individuals receiving the ... presented to Carsten Bokemeyer, Heikki Joensuu and Peter ... Congress, 26-30 September, Madrid, Spain. , Carsten Bokemeyer ... to accelerate the transition of cancer discovery into ...
    (Date:8/22/2014)... 22, 2014 Braverman Eye Center is ... Lauderdale at the most affordable fee. They are on ... their advanced Lasik treatments. LASIK is a highly successful ... Eye Center has been delivering successful LASIK solutions to ... glasses-free and contact lenses-free life with the help of ...
    (Date:8/22/2014)... The report "Higher Education Market [Software Solutions, Content ... Student & Curriculum, Performance Management] - Worldwide Market ... global Higher Ed market into various sub-segments with ... The report also identifies the factors driving this ... with the adoption trends. , Browse more ...
    (Date:8/22/2014)... Each year approx. 265,000 Danes are acutely admitted to ... from Aarhus University and Aarhus University Hospital now shows ... fourth patient are sent home again without receiving ... the acute hospitalisation., "Naturally, there is no need for ... that there is a serious illness. So some patients ...
    (Date:8/22/2014)... a wide range of epigenetic changesalterations in DNA across ... children with Crohn,s disease (CD), reports Inflammatory Bowel ... Colitis Foundation of America (CCFA). The journal is ... of Wolters Kluwer Health . , The ... regions of the genome in children with CD, according to ...
    Breaking Medicine News(10 mins):Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Braverman Eye Center Now Offers Lasik Treatment in Fort Lauderdale at the Most Affordable Fee 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Many patients are discharged without a diagnosis 2Health News:Study shows epigenetic changes in children with Crohn's disease 2
    ... GIFT IDEA FOR THE DOG, CAT, ANIMAL LOVER ON YOUR LIST ... Betty White, Emmy-award winner and TV legend, is also one of ... more than 40 years, she has been a tremendous supporter of ... of the organization,s board of trustees and is a current trustee. ...
    ... TV Movie Portrayal of Tourette Syndrome , ... million people watched last Sunday night,s Hallmark Hall of Fame ... on the true story of a young man,s struggles with ... winning teacher. The national Tourette Syndrome Association, Inc. (TSA) ...
    ... could be part of mental exercise routine for older ... Older people who want to stay sharp should reconsider ... children and pick up a joystick themselves, a new ... playing video games has many positive benefits, ranging from ...
    ... in the clinic and the laboratory continue to work ... drugs. With tamoxifen,s discovery 30 years behind us, and ... studying zoledronic acid, aromatase inhibitors and monoclonal antibodies, among ... the CTRC-AACR San Antonio Breast Cancer Symposium. , ...
    ... of the largest studies in hormone receptor positive women ... , PHILADELPHIA, Dec. 11 New results ... (lapatinib) plus Femara(R) (letrozole) versus letrozole alone as a ... breast cancer. In the study, women diagnosed with post-menopausal, ...
    ... Sister Carol Keehan, DC, president and chief executive officer ... issued the following statement: , , ... nomination today of former Senate Majority Leader Tom Daschle to ... person to oversee a new White House Office of Health ...
    Cached Medicine News:Health News:Betty White's Video States Support for Funding Humane Research to Help Pets and Wild Animals - Actress is 40-Year Champion of Morris Animal Foundation 2Health News:Hallmark Hall of Fame Collaboration with Patient Organization Equals Extraordinary Success 2Health News:Playing Video Games May Boost Older Brains 2Health News:Playing Video Games May Boost Older Brains 3Health News:Cancer drugs in the pipeline 2Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 2Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 3Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 4Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 5Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 6Health News:Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer 7Health News:Catholic Health Association Statement on the Naming of Tom Daschle and Jeanne Lambrew to Health Leadership Positions in President-Elect Obama's Administration 2
    ... Renu Multiplus preservative free lubricating ... moisturize your eyes while you're ... gentle preservative free formula is ... be sensitive to preservatives and ...
    ... Multiplus No Rub formula is the most ... All steps in one bottle without the ... soft contact lenses and removes protein build-up ... solution that contains Hydranate, a special ingredient ...
    ... Sensitive Eyes saline solution ... saline solution for people ... solution for rinsing soft ... or chemical disinfection. May ...
    ... enzymatic cleaner is a fast-acting ... stubborn deposits in as little ... enzymatic cleaner contains an enzyme ... film on soft contact lenses ...
    Medicine Products: